Evidence map›Paper›PMID 33419956›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Mammalian cell proliferation requires noncatalytic functions of O-GlcNAc transferase.

Zebulon G Levine, Sarah C Potter, Cassandra M Joiner, George Q Fei, Behnam Nabet, Matthew Sonnett, Natasha E Zachara, Nathanael S Gray, Joao A Paulo, Suzanne Walker

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Perturbing nuclear glycosylation in the mouse preimplantation embryo slows down embryonic development.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Identification of a Polypeptide Inhibitor ofJournal of the American Chemical Society · 2024
    Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Dissecting OGT's TPR domain to identify determinants of cellular function.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zebulon G LevineDepartment of Microbiology, Blavatnik Institute of Harvard Medical School, Boston, MA 02115.ORCID https://orcid.org/0000-0002-0830-9032
Sarah C PotterDepartment of Microbiology, Blavatnik Institute of Harvard Medical School, Boston, MA 02115.ORCID https://orcid.org/0000-0002-6808-180X
Cassandra M JoinerDepartment of Chemistry, St. Olaf College, Northfield, MN 55057.ORCID https://orcid.org/0000-0003-0476-9418
George Q FeiDepartment of Microbiology, Blavatnik Institute of Harvard Medical School, Boston, MA 02115.ORCID https://orcid.org/0000-0002-8008-0690
Behnam NabetDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115.ORCID https://orcid.org/0000-0002-6738-4200
Matthew SonnettDepartment of Systems Biology, Blavatnik Institute of Harvard Medical School, Boston, MA 02115.
Natasha E ZacharaDepartment of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Nathanael S GrayDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115.ORCID https://orcid.org/0000-0001-5354-7403
Joao A PauloDepartment of Cell Biology, Blavatnik Institute of Harvard Medical School, Boston, MA 02115.ORCID https://orcid.org/0000-0002-4291-413X
Suzanne WalkerDepartment of Microbiology, Blavatnik Institute of Harvard Medical School, Boston, MA 02115; suzanne_walker@hms.harvard.edu.ORCID https://orcid.org/0000-0002-0545-914X

Funding

TRANSLATIONAL PHARMACOLOGY COREP50GM107618 · NIGMS · HARVARD MEDICAL SCHOOL · PI SORGER, PETER KARL · 2014 to 2018
$10.8M
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule DrugsU54CA225088 · NCI · HARVARD MEDICAL SCHOOL · PI SHARPE, ARLENE H. · 2018 to 2022
$10.8M
Structure, Function and Inhibition of Human O-GlcNAc TransferaseR01GM094263 · NIGMS · HARVARD MEDICAL SCHOOL · PI WALKER, SUZANNE · 2012 to 2024
$5.8M
Immersive Training in GlycosciencesK12HL141952 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI HASCALL, VINCENT CHARLES, SCHNAAR, RONALD L · 2018 to 2022
$4.8M
Principles of Scientific Citizenship: Ethics, Communication, and Leadership for ScientistsT32GM095450 · NIGMS · HARVARD UNIVERSITY · PI WALKER, SUZANNE · 2011 to 2020
$3.5M
Advancing Multiplexed Isobaric Tag-based Strategies for Proteome ProfilingR01GM132129 · NIGMS · HARVARD MEDICAL SCHOOL · PI PAULO, JOAO A · 2019 to 2023
$1.7M
Tuning and Tagging the O-GlcNAc ModificationU01CA230978 · NCI · JOHNS HOPKINS UNIVERSITY · PI ZACHARA, NATASHA ELIZABETH · 2018 to 2020
$1.3M
Using Quantitative Proteomics to Understand Mitotic Spindle Composition and FunctionF31GM116451 · NIGMS · HARVARD MEDICAL SCHOOL · PI SONNETT, MATTHEW MCLEAN · 2015 to 2017
$131k
Characterizing the O-GIcNAc Transferase Tetratricopeptide Repeat Domain's Role in Substrate SelectionF32GM129889 · NIGMS · HARVARD MEDICAL SCHOOL · PI JOINER, CASSANDRA MARIE · 2019 to 2019
$62k
NCI NIH HHS U01 CA230978NCI NIH HHS U54 CA225088NHLBI NIH HHS K12 HL141952NIGMS NIH HHS F31 GM116451NIGMS NIH HHS F32 GM129889NIGMS NIH HHS P50 GM107618NIGMS NIH HHS R01 GM094263NIGMS NIH HHS R01 GM132129NIGMS NIH HHS T32 GM095450
6 · The paper itself

Abstract

O-GlcNAc transferase (OGT), found in the nucleus and cytoplasm of all mammalian cell types, is essential for cell proliferation. Why OGT is required for cell growth is not known. OGT performs two enzymatic reactions in the same active site. In one, it glycosylates thousands of different proteins, and in the other, it proteolytically cleaves another essential protein involved in gene expression. Deconvoluting OGT's myriad cellular roles has been challenging because genetic deletion is lethal; complementation methods have not been established. Here, we developed approaches to replace endogenous OGT with separation-of-function variants to investigate the importance of OGT's enzymatic activities for cell viability. Using genetic complementation, we found that OGT's glycosyltransferase function is required for cell growth but its protease function is dispensable. We next used complementation to construct a cell line with degron-tagged wild-type OGT. When OGT was degraded to very low levels, cells stopped proliferating but remained viable. Adding back catalytically inactive OGT rescued growth. Therefore, OGT has an essential noncatalytic role that is necessary for cell proliferation. By developing a method to quantify how OGT's catalytic and noncatalytic activities affect protein abundance, we found that OGT's noncatalytic functions often affect different proteins from its catalytic functions. Proteins involved in oxidative phosphorylation and the actin cytoskeleton were especially impacted by the noncatalytic functions. We conclude that OGT integrates both catalytic and noncatalytic functions to control cell physiology.

Indexed as

AnimalsCell ProliferationFibroblastsGene Expression ProfilingGene Expression RegulationGene Knockout TechniquesGene OntologyGenetic Complementation TestGlycosylationHEK293 CellsHost Cell Factor C1HumansMetabolic Networks and PathwaysMiceMolecular Sequence AnnotationN-AcetylglucosaminyltransferasesHCFC1 protein, humanHost Cell Factor C1N-AcetylglucosaminyltransferasesOGT protein, humanOgt protein, mousecell proliferationenzymeHCF-1O-GlcNAc transferaseOGT

Identifiers

PMID33419956
PMCPMC7848692

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.